By submitting, you consent that you are at least 18 years of age and to receive information about MPR's or APMG entities' programs and offerings. The personally identifying information you provide will not be sold, shared, or used for purposes other than to communicate with you about MPR, APMG entities, and its sponsors. You may opt-out at any time clicking the unsubscribe link at the bottom of any email communication. View our Privacy Policy.
The FDA called the vaccine from Pfizer and its German partner BioNTech safe and strongly protective. But initial doses are scarce and rationed, with health workers and nursing home residents first in line. Enough for the general population isn't expected until spring.
Dr. Jeff Bahr with the Advocate Aurora Health system in Wisconsin says his hospitals are "ready to go" for vaccinations. Staff who treat COVID-19 patients will be first in line, he says.
The number of people who want a COVID-19 vaccine far outweighs the number of doses currently available. MPR host Kerri Miller asked a vaccine researcher and a bioethicist about the best practices and challenges of distributing vaccines in a global pandemic.
The Food and Drug Administration's authorization of a COVID-19 vaccine could come in a day or two, a member of an FDA expert panel says. But he says it may be late 2021 before normalcy returns.
For many college students this year, the decision to go home for the holidays is not an easy one. Three college students recently reflected on their 2020 Thanksgiving experience and what their plans are for winter break.
As the weeks go by with hospitals beds full and staff in short supply, doctors and nurses are under incredible pressure. One Minnesota doctor says she’s worried it’ll lead to an exodus of providers after the pandemic.